Close Menu

NEW YORK (GenomeWeb) – Horizon Discovery today announced it has licensed technology from ERS Genomics related to the CRISRP-Cas9 gene editing system.

Under the terms of the non-exclusive agreement, Horizon can use the technology for research applications, such as the development and sale of research tools, kits, and reagents; performance of research services; development of genetically modified disease model cell lines; development and production of reference standard materials for molecular diagnostics; and internal target identification and validation research.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.